Ignite Creation Date:
2024-05-06 @ 10:41 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03326921
Status:
SUSPENDED
Last Update Posted:
2024-03-21
First Post:
2017-10-05
Brief Title:
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |
| Juvenile Myelomonocytic Leukemia |
| Recurrent Acute Biphenotypic Leukemia |
| Recurrent Acute Undifferentiated Leukemia |
| Recurrent Childhood Acute Lymphoblastic Leukemia |
| Recurrent Childhood Acute Myeloid Leukemia |
| Refractory Acute Lymphoblastic Leukemia |
| Refractory Adult Acute Lymphoblastic Leukemia |
| Blast Phase Chronic Myelogenous Leukemia BCR-ABL1 Positive |
| Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm |
| Recurrent Myelodysplastic Syndrome |
| Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm |
| Refractory Myelodysplastic Syndrome |
| Acute Undifferentiated Leukemia |
| Mixed Phenotype Acute Leukemia |
| Recurrent Chronic Myelogenous Leukemia BCR-ABL1 Positive |
| Refractory Chronic Myelogenous Leukemia BCR-ABL1 Positive |
| Recurrent Acute Lymphoblastic Leukemia |
| Recurrent Acute Myeloid Leukemia |
| Myelodysplastic Syndrome |
| Acute Myeloid Leukemia |
| Acute Lymphoblastic Leukemia |
| Acute Biphenotypic Leukemia |
| Chronic Myeloid Leukemia |
| Chronic Myelomonocytic Leukemia |
| Minimal Residual Disease |
| Recurrent Chronic Myelomonocytic Leukemia |
| Recurrent Mixed Phenotype Acute Leukemia |